BPC 157 (X acetate)

Body Protection Compound 157 (BPC 157) is a pentadecapeptide derived from BPC, identified in gastric juice, exhibiting diverse biological activities. At 2 μg/ml, BPC 157 enhances primary rat tendon fibroblast cell migration and F-actin formation. Furthermore, doses of 0.01 and 10 μg/kg, intraperitoneally (i.p.), mitigate paw swelling, bone erosion, and mononuclear cell infiltration in the joints of rats with rheumatoid arthritis induced by complete Freund's adjuvant (CFA) . It also diminishes gastric ulcer size in rats caused by indomethacin, aspirin, or diclofenac at these doses. Additionally, BPC 157 reduces catalepsy duration and tremor severity in a mouse model of Parkinson's disease triggered by MPTP.

C(C)(O)=O.C(=O)(N1[C@H](C(=O)N2[C@H](C(NCC(N[C@H](C(=O)N3[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@@H]([C@H](C)C)C(O)=O)=O)CC(C)C)=O)=O)C)=O)CC(O)=O)=O)CC(O)=O)=O)C)=O)CCC3)CCCCN)=O)=O)CCC2)CCC1)[C@H]4N(C([C@@H](NC(CN)=O)CCC(O)=O)=O)CCC4